Atlas Laboratories And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 7.88 Cr
- Company Age 42 Year, 11 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 32.00 Cr
- Satisfied Charges ₹ 9.00 Cr
About Atlas Laboratories And Pharmaceuticals
Atlas Laboratories And Pharmaceuticals Limited (ALAPL) is a Public Limited Indian Non-Government Company incorporated in India on 02 March 1982 and has a history of 42 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 7.88 Cr.
The company currently has active open charges totaling ₹32.00 Cr. The company has closed loans amounting to ₹9.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Salil Kapur, Suresh Gupta, Pradeep Kumar, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1982PLC013227
- Company No.
013227
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Mar 1982
- Date of AGM
29 Sep 2010
- Date of Balance Sheet
31 Mar 2010
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Atlas Laboratories And Pharmaceuticals?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Salil Kapur ![]() | Director | 10-Aug-1991 | Current |
Suresh Gupta ![]() | Director | 30-Jul-2007 | Current |
Pradeep Kumar ![]() | Director | 16-May-2011 | Current |
Sumit Saini ![]() | Additional Director | 31-Aug-2018 | Current |
Financial Performance of Atlas Laboratories And Pharmaceuticals.
Enhance accessibility to Atlas Laboratories And Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Atlas Laboratories And Pharmaceuticals?
Unlock access to Atlas Laboratories And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹32.00 Cr
₹9.00 Cr
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 32.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
01 May 2008 | Indian Overseas Bank | ₹5.00 Cr | Open |
14 Jan 2006 | Indian Overseas Bank | ₹20.00 Cr | Open |
14 Jan 2006 | Indian Overseas Bank | ₹7.00 Cr | Open |
31 Aug 2009 | S. E. Investments Limited | ₹4.50 Cr | Satisfied |
29 Aug 2009 | S. E. Investments Limited | ₹4.50 Cr | Satisfied |
How Many Employees Work at Atlas Laboratories And Pharmaceuticals?
Unlock and access historical data on people associated with Atlas Laboratories And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Atlas Laboratories And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atlas Laboratories And Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.